导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -4.10% | 695/1050 |
| 近一周 | -0.93% | 438/1104 |
| 近一月 | -0.14% | 136/1103 |
| 近一季 | 2.07% | 203/1092 |
| 近半年 | -10.82% | 798/1070 |
| 近一年 | -1.50% | 619/1018 |
| 近两年 | 23.07% | 746/926 |
| 近三年 | 22.03% | 481/834 |
| 成立以来 | 125.17% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.44% 301/1070 |
-12.41% 971/1101 |
- - |
- - |
| 2025 | 13.19% 785/1065 |
4.04% 478/1014 |
0.05% 677/1038 |
7.09% 899/1050 |
1.54% 344/1065 |
| 2024 | 20.99% 81/1011 |
10.15% 30/960 |
4.56% 115/983 |
5.21% 877/991 |
-0.16% 330/1011 |
| 2023 | -4.31% 186/952 |
0.38% 612/880 |
0.71% 151/895 |
1.48% 49/915 |
-6.73% 650/952 |
| 2022 | -34.56% 701/867 |
-29.87% 735/773 |
6.48% 437/806 |
-4.98% 66/845 |
-7.78% 730/867 |
| 2021 | 13.29% 202/740 |
-13.86% 541/580 |
22.08% 129/659 |
2.26% 182/704 |
5.36% 208/740 |
| 2020 | 53.38% 224/554 |
0.46% 153/419 |
34.18% 78/466 |
-2.21% 441/517 |
16.35% 180/554 |
| 2019 | 81.47% 7/410 |
32.98% 220/1146 |
-7.40% 880/1228 |
18.59% 20/390 |
24.28% 4/410 |
| 2018 | -19.05% 60/349 |
- - |
-10.99% 545/990 |
-7.27% 600/1000 |
-3.93% 45/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 南方产业智选股票A VS. 东吴新产业精选股票A(580008) |